PHK
CCXI

Point72 Hong Kong’s ChemoCentryx, Inc. CCXI Stock Holding History

Point72 Hong Kong’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,207
Closed -$55K – 2568
2022
Q1 		$55K Sell
2,207
-947
-30% -$26.6K ﹤0.01% 1314
2021
Q4 		$115K Buy
+3,154
New +$111K ﹤0.01% 1149
2020
Q4 		– Sell
-2,819
Closed -$154K – 2138
2020
Q3 		$154K Buy
+2,819
New +$152K 0.02% 495
2019
Q3 		– Sell
-161
Closed -$1K – 1455
2019
Q2 		$1K Sell
161
-627
-80% -$7.26K ﹤0.01% 1075
2019
Q1 		$11K Buy
+788
New +$9.01K ﹤0.01% 758
2018
Q3 		– Sell
-93
Closed -$1K – 1274
2018
Q2 		$1K Buy
+93
New +$1.11K ﹤0.01% 851

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Point72 Hong Kong's CCXI Position: Q2 2022 in Review

Point72 Hong Kong sold out of ChemoCentryx, Inc. (CCXI) in Q2 2022, closing a stake of 2,207 shares — an estimated $55K sold.

Point72 Hong Kong first reported a position in CCXI in Q2 2018 and held it in 6 quarters. The position peaked at $154K in Q3 2020. 182 funds tracked by Wall St. Rank hold CCXI as of Q2 2022.

  • Point72 Hong Kong reported no remaining ChemoCentryx, Inc. position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 2,207 ChemoCentryx, Inc. shares in Q2 2022, an estimated $55K.
  • Point72 Hong Kong first reported a position in ChemoCentryx, Inc. in Q2 2018 and held it in 6 quarters.
  • Point72 Hong Kong's ChemoCentryx, Inc. position peaked at $154K in Q3 2020.
  • 182 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.